DE:4XB / XBiotech Inc. - Net Long/Short Value

X生技公司
DE ˙ DB ˙ CA98400H1029
€1.91 ↓ -0.13 (-6.24%)
2026-06-04
分享價格
DE:4XB / XBiotech Inc. - Net Long/Short Value
此頁面顯示了每個機構通過13F或NPORT提交的持股報告中,其投資組合的凈長倉/短倉估值。我們計算凈長倉/短倉價值的方式是將股權價值和認購期權價值相加,再減去認沽期權價值。如果機構披露了借股的淡倉價值,則股權價值將以負數列示。净長倉在凈長倉/短倉列中将以正数列示,而净短倉在该列中則以負數列示。
持有者 權益價值
(千美元)
認購期權價值
(千美元)
認沽期權價值
(千美元)
淨長倉/短倉
(千美元)
Vanguard Global Advisers, LLC
Bridgeway Capital Management Inc
Vanguard Group Inc
Optiver Holding B.V.
Jpmorgan Chase & Co
Simplex Trading, Llc
Susquehanna International Group, Llp
Two Sigma Advisers, Lp
RBF Capital, LLC
Qube Research & Technologies Ltd
Morgan Stanley
McIlrath & Eck, LLC
SBI Securities Co., Ltd.
Rhumbline Advisers
Bnp Paribas Arbitrage, Sa
SRS Capital Advisors, Inc.
State Street Corp
Millennium Management Llc
Dimensional Fund Advisors Lp
National Bank Of Canada /fi/
XTX Topco Ltd
Jones Financial Companies Lllp
Connor, Clark & Lunn Investment Management Ltd.
Bank Of America Corp /de/
BlackRock, Inc.
Northern Trust Corp
Renaissance Technologies Llc
Caitong International Asset Management Co., Ltd
Empowered Funds, LLC
Squarepoint Ops LLC
Vanguard Capital Management Llc
Bank of New York Mellon Corp
Pinnacle Financial Partners, Inc.
Thomasville National Bank
Geode Capital Management, Llc
Royal Bank Of Canada
UBS Group AG
Barclays Plc
Jane Street Group, Llc
American Century Companies Inc
Cwm, Llc
Larson Financial Group LLC
Vanguard Fiduciary Trust Co
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:XBIT US$2.37
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista